Latest close
$179.39
As of Oct 9, 2026
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Patient Capital Management | 2.21% | 462,016 | ADDED (+7.3%) |
Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end. Fund counts here aggregate every share class mapped to this ticker; research headlines cite filer counts as they stood at publication, so a count here can differ from a headline by a holder (see Methodology, "How holder counts are counted").
| Institutions holding | 1,125 of 8,857 filers |
| Long-only filers among them | 1,113 |
| Change vs 2026 Q1 | -54 net · 971 entered · 1,025 exited |
| Shares reported, all filers | 144,697,310 |
| Reported value, all filers | $32.3B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | Nasdaq |
| Industry | Finance Services (SIC 6199) |
| Revenue · FY2025 | $7.2B |
| Net income · FY2025 | $1.3B |
| Total assets · FY2025 | $29.7B |
| Shares outstanding | 263,782,000 |
| Market cap (at latest close) | $47.3B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 7, 2026. Shares outstanding as reported Jun 30, 2026.
| Shares short · Sep 15, 2026 | 25,234,463 |
| Share of shares outstanding | 9.57% |
| Days to cover | 2.78 |
Shares short at recent settlements — Jun 30, 2026: 24.9M · Jul 15, 2026: 25.0M · Jul 31, 2026: 21.8M · Aug 14, 2026: 22.9M · Aug 31, 2026: 27.4M · Sep 15, 2026: 25.2M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jun 30, 2026.
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 29 sales by 4 insiders ($19.1M).
Source: SEC Form 4 filings, as of Oct 11, 2026. Open-market transactions only.
1 member of Congress reported buying (2 purchases vs 2 sales). Bought by Democrats. Latest buy: Jul 17, 2026.
Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Oct 3, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.
Politicians
· Bought by Members — Last 6 months: bought by a member of the U.S. Congress
Financial Screens
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
Key figures
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 3.41 · Operating cash flow: $2.4B · Net income: $1.3B
· Bought by Members — Members buying: 1 · Buy txns: 2 · Sell txns: 2 · Latest buy: Jul 17, 2026
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Politician BEST — appeared in 2 of the last 20 quarterly lists; latest 2021 Q4, ranked #31 of 50.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 2 | 100.0% | +30.8% | +6.4% | +24.5% |
| Share count tripled (3x) | 1 | 100.0% | +24.0% | +1.9% | +22.1% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.